Lasa Supergenerics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics Limited has submitted its audited financial results for the period ended March 31, 2025 to the stock exchange. The filing is a regulatory compliance disclosure confirming that the company's full-year (or period-end) financial statements have been filed. No specific financial figures, revenue details, profit/loss numbers, or auditor commentary are included in the announcement text itself. Investors would need to refer to the actual financial results document for detailed numbers and any management or auditor observations.
This is a procedural compliance filing and does not by itself indicate any positive or negative development. Shareholders should review the detailed financial results document for actual performance metrics and any auditor remarks that could affect the company's outlook.